|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta显示文摘 | Matthias Peuster Carola Hesse Tirza Schloo Christoph Fink Philipp Beerbaum Christian von Schnakenburg | 2006 | Biomaterials2006，，28： | 2 |
| 2 | Allergic airway inflammation inhibits pulmonary antibacterial host defense显示文摘 | CHRISTOPH B KERSTIN K HESS C | 2006 | J Immunol2006，177，： | 1 |
| 3 | Gaia: A middleware irffrastrueture to enable active spaces 显示文摘 | Manuel Roman Christopher Hess Renato Cerqueira | 2002 | IEEE Pervasive Computing2002，1，4： | 1 |
| 4 | Gaia:A middleware infrastructure to enable active spaces显示文摘 | Manuel Roman Christopher Hess Renato Cerqueira | 2002 | IEEE Pervasive Computing2002，1，4： | 1 |
| 5 | Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration显示文摘 | Tara M. Breslin MD Kenneth R. Hess PhD Dana B. Harbison MD Marina E. Jean MD Karen R. Cleary MD Alan P. Dackiw MD Robert A. Wolff MD James L. Abbruzzese MD Nora A. Janjan MD Christopher H. Crane MD J. Nicolas Vauthey MD Jeffrey E. Lee MD Peter W. T. Piste | 2001 | Annals of Surgical Oncology2001，，2： | 1 |
| 6 | Selective Activation, Different Branching and Grafting of Poly(propylenimine)-Dendrimers显示文摘 | Andreas Archut Sven Gestermann Richard Hesse Christopher Kauffmann Fritz Vogtle | 1998 | Synlett1998，1998，： | 1 |
| 7 | Allergic airway inflammation inhibits pulmonary antibacterial host defense 显示文摘 | Christoph Beisswenger Kerstin Kandler Hess C | 2006 | J Immunol2006，177，3： | 1 |
| 8 | A Middleware Infrastructure to Enable Active Spaces 显示文摘 | Manuel Roman Christopher Hess Renato Cerqueira | 2002 | IEEE Pervasive Computing2002，1，4： | 1 |
| 9 | Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation显示文摘Aim:To test the hypothesis that lymphocyte infiltration in brain arteriovenous malformation(bAVM)is not associated with iron deposition(indicator of micro-hemorrhage).Methods:Sections of unruptured,previously untreated bAVM specimens(n=19)were stained immunohistochemically for T-lymphocytes(CD3+),B-lymphocytes(CD20+),plasma cells(CD138+)and macrophages(CD68+).Iron deposition was assessed by hematoxylin and eosin and Prussian blue stains.Superficial temporal arteries(STA)were used as control.Results:Both T-lymphocytes and macrophages were present in unruptured,previously untreated bAVM specimens,whereas few B cells and plasma cells were detected.Iron deposition was detected in 8 specimens(42%;95%confidence intervals=20-67%).The samples with iron deposition tended to have more macrophages than those without(666±313 vs.478±174 cells/mm2;P=0.11).T-cells were clustered on the luminal side of the endothelial surface,on the vessel-wall,and in the perivascular regions.There was no correlation between T-lymphocyte load and iron deposition(P=0.88).No macrophages and lymphocytes were detected in STA controls.Conclusion:T-lymphocytes were present in bAVM specimens.Unlike macrophages,the load and location of T-lymphocytes were not associated with iron deposition,suggesting the possibility of an independent cell-mediated immunological mechanism in bAVM pathogenesis. | Yi Guo Tarik Tihan Helen Kim Christopher Hess Michael T.Lawton William L.Young Yuan-Li Zhao Hua Su | 2014 | Neuroimmunology and Neuroinflammation2014，1，1： | 1 |
| 10 | Cardiac risk after mediastinal irradiation for Hodgkin’s disease显示文摘 | Christoph Glanzmann Philipp Kaufmann Rolf Jenni Othmar M Hess Pia Huguenin | 1998 | Radiotherapy and Oncology1998，，1： | 1 |
| 11 | Modeling of Real Defect Outlines and Parameter Extraction Using a Checkerboard Test Structure to Localize Defects 显示文摘 | Christopher Hess Albrecht P Stroele | 1994 | IEEE Transactions on Semiconductor Manufacturing1994，7，34： | 1 |
| 12 | Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration显示文摘 | Tara M. Breslin MD Kenneth R. Hess PhD Dana B. Harbison MD Marina E. Jean MD Karen R. Cleary MD Alan P. Dackiw MD Robert A. Wolff MD James L. Abbruzzese MD Nora A. Janjan MD Christopher H. Crane MD J. Nicolas Vauthey MD Jeffrey E. Lee MD Peter W. T. Piste | 2001 | Annals of Surgical Oncology2001，，2： | 1 |
| 13 | Mammalian nest predators respond to greenway width, landscape context and habitat structure显示文摘 | Kristen E. Sinclair George R. Hess Christopher E. Moorman Jamie H. Mason | 2004 | Landscape and Urban Planning2004，，2： | 1 |
| 14 | The effects of oil exposure and weathering on black-needle rush(Juncus roemerianus) marshes along the Gulf of Mexico显示文摘 | Christopher J Anderson Thomas A Hess | 2012 | Marine Pollution Bulletin2012，，64： | 1 |
| 15 | Elevated plasma levels of N-terminal pro-brain natriuretic peptide in patients with chronic hepatitis C during interferon-based antiviral therapy显示文摘AIM: To investigate plasma levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), an established marker of cardiac function, in patients with chronic hepatitis C during interferon-based antiviral therapy. METHODS: Using a sandwich immunoassay, plasma levels of NT-proBNP were determined in 48 patients with chronic hepatitis C at baseline, wk 24 and 48 during antiviral therapy and at wk 72 during follow-up.RESULTS: Plasma NT-proBNP concentrations were significantly increased (P < 0.05) at wk 24, 48 and 72 compared to the baseline values. NT-proBNP concentrations at baseline and wk 24 were closely correlated (r = 0.8; P < 0.001). At wk 24, 7 (14.6%) patients had NT-proBNP concentrations above 200 ng/L compared to 1 (2%) patient at baseline (P = 0.059). Six of these 7 patients had been treated with high-dose IFN-α induction therapy. In multiple regression analysis, NT-proBNP was not related to other clinical parameters, biochemical parameters of liver disease or virus load and response to therapy.CONCLUSION: Elevated levels of NT-proBNP during and after interferon-based antiviral therapy of chronic hepatitis C may indicate the presence of cardiac dysfunction, which may contribute to the clinical symptoms observed in patients during therapy. Plasma levels of NT-proBNP may be used as a diagnostic tool and for guiding therapy in patients during interferon-based antiviral therapy. | Jrg Bojunga Christoph Sarrazin Georg Hess Stefan Zeuzem | 2006 | World Journal of Gastroenterology2006，12，36： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员